Privium Fund Management B.V. Uni Qure N.V. Transaction History
Privium Fund Management B.V.
- $469 Million
- Q2 2025
A detailed history of Privium Fund Management B.V. transactions in Uni Qure N.V. stock. As of the latest transaction made, Privium Fund Management B.V. holds 447,486 shares of QURE stock, worth $6.4 Million. This represents 1.33% of its overall portfolio holdings.
Number of Shares
447,486
Previous 579,139
22.73%
Holding current value
$6.4 Million
Previous $6.14 Million
1.61%
% of portfolio
1.33%
Previous 1.61%
Shares
14 transactions
Others Institutions Holding QURE
# of Institutions
175Shares Held
50.6MCall Options Held
2.12MPut Options Held
455K-
Vestal Point Capital, LP New York, NY4.79MShares$68.5 Million3.63% of portfolio
-
Rtw Investments, LP New York, NY4.27MShares$61 Million0.74% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.99MShares$57 Million3.32% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.76MShares$39.4 Million1.32% of portfolio
-
Abrdn PLC2.75MShares$39.3 Million0.07% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $668M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...